Shipping exclusively to Alberta, BC, and Ontario at this time. Free ground shipping for all orders $80+.

0

Your Cart is Empty

Crocodilia-MAINT Canine Bag

Crocodilia-MAINT™ canine dry diets contain a limited number of highly digestible ingredients making them appropriate for an elimination diet trial and maintenance options in dogs suspected to have allergic dermatologic or gastrointestinal disease.

  • Crocodilia-MAINT™ canine dry diets contain a limited number of highly digestible ingredients making them appropriate for an elimination diet trial and maintenance options in dogs suspected to have allergic dermatologic or gastrointestinal disease.

    Alligator provides a unique novel protein source, while limited carbohydrates include chickpea or quinoa. Algae provides a vegetable omega-3 source in order to manage the most sensitive allergy patients. Higher omega-3 fatty acids (EPA/DHA/DPA) contribute to reducing inflammation. An optimal blend of fibre and the addition of prebiotics helps to maintain gastrointestinal health.

     Click HERE to view the detailed diet page.

  • Dried chickpeas, alligator, dried peas, potato flour, pea protein, natural flavor, sunflower oil, (preserved with mixed tocopherols), coconut oil, calcium carbonate, marine microalgae, fructooligosaccharides, salt, dicalcium phosphate, vitamins, dl-methionine, choline chloride, minerals, taurine, mixed tocopherols, rosemary extract.
    1. Unique animal-source novel protein (alligator)
    2. No animal fat, corn or wheat (potential allergen sources)
    3. Unique vegetable omega-3 source provides higher levels of omega fatty acids (EPA/DHA/DPA)
    4. Moderately low phosphorus content
    5. Low sodium content
    6. Moderate fat content
    7. Added prebiotics (fructooligosaccharides)
    1. Non-copper-associated liver disease (patient dependent)
    2. Adverse reactions to food (dermatologic and gastrointestinal)
    3. Adverse reactions to food (dermatologic and gastrointestinal) with concurrent disease
    • IRIS stage 1 and 2 +/- stage 3 renal disease
    • Consideration for individual patients with proteinuric renal disease